262 related articles for article (PubMed ID: 9477126)
21. Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party.
Hann IM; Richards SM; Eden OB; Hill FG
Leukemia; 1998 Aug; 12(8):1249-55. PubMed ID: 9697880
[TBL] [Abstract][Full Text] [Related]
22. Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells.
Hurwitz CA; Gore SD; Stone KD; Civin CI
Leukemia; 1992 Apr; 6(4):233-9. PubMed ID: 1375301
[TBL] [Abstract][Full Text] [Related]
23. Lack of CD24 antigen expression in B-lineage acute lymphoblastic leukemia is associated with intrinsic radiation resistance of primary clonogenic blasts.
Uckun FM; Song CW
Blood; 1993 Mar; 81(5):1323-32. PubMed ID: 8443393
[TBL] [Abstract][Full Text] [Related]
24. CD19 negative precursor B acute lymphoblastic leukemia (B-ALL)-Immunophenotypic challenges in diagnosis and monitoring: A study of three cases.
Ghodke K; Bibi A; Rabade N; Patkar N; Subramanian PG; Kadam PA; Badrinath Y; Ghogale S; Gujral S; Tembhare P
Cytometry B Clin Cytom; 2017 Jul; 92(4):315-318. PubMed ID: 27018867
[TBL] [Abstract][Full Text] [Related]
25. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study.
Trueworthy R; Shuster J; Look T; Crist W; Borowitz M; Carroll A; Frankel L; Harris M; Wagner H; Haggard M
J Clin Oncol; 1992 Apr; 10(4):606-13. PubMed ID: 1548523
[TBL] [Abstract][Full Text] [Related]
26. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
Ciudad J; Orfao A; Vidriales B; Macedo A; Martínez A; González M; López-Berges MC; Valverde B; San Miguel JF
Haematologica; 1998 Dec; 83(12):1069-75. PubMed ID: 9949623
[TBL] [Abstract][Full Text] [Related]
27. The immunophenotype in infant acute lymphoblastic leukaemia: correlation with clinical outcome. An Italian multicentre study (AIEOP).
Basso G; Putti MC; Cantú-Rajnoldi A; Saitta M; Santostasi T; Santoro N; Lippi A; Comelli A; Felici L; Favre C
Br J Haematol; 1992 Jun; 81(2):184-91. PubMed ID: 1643015
[TBL] [Abstract][Full Text] [Related]
28. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
29. [Comparison of the immunophenotype of patients with B lineage acute lymphoblastic leukemia at diagnosis and relapse].
Liu YR; Chang Y; Fu JY; Cheng YF; Zhang LP; Li LD; Wang H; Liu GL; Chen SS; Huang XJ; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):335-8. PubMed ID: 16875586
[TBL] [Abstract][Full Text] [Related]
30. Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87). French Group on Therapy for Adult Acute Lymphoblastic Leukemia.
Boucheix C; David B; Sebban C; Racadot E; Bené MC; Bernard A; Campos L; Jouault H; Sigaux F; Lepage E
Blood; 1994 Sep; 84(5):1603-12. PubMed ID: 8068949
[TBL] [Abstract][Full Text] [Related]
31. [Monitoring of minimal residual disease in children with acute lymphoblastic leukemia and its prognostic significance].
Xu XJ; Tang YM; Song H; Shi SW; Yang SL; Shen HQ; Wei J; Xu WQ; Pan BH; Zhao FY
Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):180-4. PubMed ID: 20426951
[TBL] [Abstract][Full Text] [Related]
32. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
Cáp J; Babusíková O; Kaiserová E; Jamárik M
Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666
[TBL] [Abstract][Full Text] [Related]
33. CD10 AND CD34 expression in childhood acute lymphoblastic leukemia in Morocco: clinical relevance and outcome.
Dakka N; Bellaoui H; Bouzid N; Khattab M; Bakri Y; Benjouad A
Pediatr Hematol Oncol; 2009 Jun; 26(4):216-31. PubMed ID: 19437324
[TBL] [Abstract][Full Text] [Related]
34. Immunophenotype of acute lymphoblastic leukemia cells: the experience of the Italian Cooperative Group (Gimema).
De Rossi G; Grossi C; Foà R; Tabilio A; Vègna L; Lo Coco F; Annino L; Camera A; Cascavilla N; Ciolli S
Leuk Lymphoma; 1993 Feb; 9(3):221-8. PubMed ID: 8471981
[TBL] [Abstract][Full Text] [Related]
35. [Immunophenotyping and its clinical significance in childhood acute lymphoblastic leukemia].
Zhang YD; Tan LN; Hu Q; Wei HY; Zhang XL; Xiong H
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Mar; 14(3):188-91. PubMed ID: 22433405
[TBL] [Abstract][Full Text] [Related]
36. Immunophenotyping of acute lymphoblastic leukemia in pediatric patients by three-color flow cytometric analysis.
Tiensiwakul P; Lertlum T; Nuchprayoon I; Seksarn P
Asian Pac J Allergy Immunol; 1999 Mar; 17(1):17-21. PubMed ID: 10403005
[TBL] [Abstract][Full Text] [Related]
37. BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation.
Lucio P; Gaipa G; van Lochem EG; van Wering ER; Porwit-MacDonald A; Faria T; Bjorklund E; Biondi A; van den Beemd MW; Baars E; Vidriales B; Parreira A; van Dongen JJ; San Miguel JF; Orfao A;
Leukemia; 2001 Aug; 15(8):1185-92. PubMed ID: 11480560
[TBL] [Abstract][Full Text] [Related]
38. Immunophenotype of normal and leukemic bone marrow B-precursors in a Brazilian population. A comparative analysis by quantitative fluorescence cytometry.
Rego EM; Garcia AB; Carneiro JJ; Falcão RP
Braz J Med Biol Res; 2001 Feb; 34(2):183-94. PubMed ID: 11175493
[TBL] [Abstract][Full Text] [Related]
39. The immunophenotypes of blast cells in B-cell precursor acute lymphoblastic leukemia: how different are they from their normal counterparts?
Sędek Ł; Bulsa J; Sonsala A; Twardoch M; Wieczorek M; Malinowska I; Derwich K; Niedźwiecki M; Sobol-Milejska G; Kowalczyk JR; Mazur B; Szczepański T
Cytometry B Clin Cytom; 2014 Sep; 86(5):329-39. PubMed ID: 24845957
[TBL] [Abstract][Full Text] [Related]
40. CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia: a Children's Cancer Group study.
Uckun FM; Steinherz PG; Sather H; Trigg M; Arthur D; Tubergen D; Gaynon P; Reaman G
Blood; 1996 Dec; 88(11):4288-95. PubMed ID: 8943865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
